Drug Topics
JUNE 14, 2024
In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.
PharmaVoice
JUNE 14, 2024
While researchers gain ground understanding long COVID’s impact, viable treatments could still be a long way off.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
JUNE 14, 2024
The CDC released an alert encouraging pharmacists and providers to counsel patients around the harms of illegal stimulant medications.
STAT
JUNE 14, 2024
News watchers around the U.S. have likely seen the warnings: without certificate of need (CON) laws, hospitals will be forced to close their doors when for-profit organizations open and cherry pick commercially insured patients, leaving those in rural areas without care. The reality is that even with certificate of need laws in place, rural patients are already without care.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
JUNE 14, 2024
Patrick Alonso, PharmD, CPh, provides some tips for men looking to improve their overall mental health.
Pharmacy Times
JUNE 14, 2024
Researchers are working to solve consistency and ecological and ethical concerns in pharmaceutical formulations
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
JUNE 14, 2024
The federal government is rescoring the quality ratings of this year’s Medicare Advantage plans, which could lead to an additional $1 billion of taxpayer money flowing into the coffers of health insurance companies. Recent court decisions required the Biden administration to make these changes to insurers’ star ratings, many of which came in lower than companies had expected and cost them hundreds of millions of dollars in bonuses.
Drug Topics
JUNE 14, 2024
In abstracts presented at the 2024 American Society of Clinical Oncology’s annual meeting, researchers addressed the association between heart failure and multiple types of cancers.
STAT
JUNE 14, 2024
Nearly nine in 10 Americans strongly believe in the overall value of childhood vaccines. Reflecting the value communities place on them, every state and the District of Columbia require children to get vaccinated against certain diseases before they start school, including measles, mumps, polio, tetanus, whooping cough, and chickenpox. Troubling stories about outbreaks of previously eradicated diseases like measles notwithstanding, most schools are free of vaccine-preventable diseases.
Drug Topics
JUNE 14, 2024
Academic, corporate, and clinical institutions must empower pharmacists to deliver informed and compassionate care to LGBTQ individuals that matches the standard received by their heterosexual and cisgender peers.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JUNE 14, 2024
WASHINGTON — Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before the Senate after Sen. Bernie Sanders threatened to subpoena the company over its pricing of the popular diabetes drug Ozempic and the obesity drug Wegovy, the Senate health committee announced Friday. The agreement is a finale to a farcical public back-and-forth over apparent difficulties between the Senate health committee and Novo in scheduling a hearing.
Drug Topics
JUNE 14, 2024
Although a recent study revealed shortcomings associated with ChatGPT and its guidance on medication use, it doesn’t rule out its potential as a valuable health care tool.
Fierce Healthcare
JUNE 14, 2024
The Drug Enforcement Administration’s long-awaited second attempt at a telemedicine prescribing rule has been handed off to the Office of Management and Budget (OMB) for review. | The Drug Enforcement Administration has submitted a proposed telehealth prescribing rule to the Office of Management and Budget which aims to regulate how telehealth providers prescribe controlled substances when the patient and provider do not have an established relationship.
Drug Topics
JUNE 14, 2024
Emily Bellan, PharmD candidate at Duquesne University, shares insights on pharmacy school applications, on-campus involvement opportunities, and career paths after graduation.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Pharma
JUNE 14, 2024
With a deal worth up to $1.3 billion, Takeda could get its hands on a “potentially best-in-class” third-generation BCR-ABL tyrosine kinase inhibitor (TKI) that could rival Novartis' Scemblix.< | In deal potentially worth up to $1.3 billion, Takeda has gained an option to license Ascentage's third-generation tyrosine kinase inhibitor, which could go up against Novartis' Scemblix in chronic myeloid leukemia.
Fierce Healthcare
JUNE 14, 2024
Tempus AI, a precision medicine company that, as its name implies, uses artificial intelligence to process medical data, popped in its stock market debut Friday, with shares jumping 15%. | Tempus AI, a precision medicine company that, as its name implies, uses artificial intelligence to process medical data, popped in its stock market debut Friday, with shares jumping 15%.
STAT
JUNE 14, 2024
LOS ANGELES – For the past two years, Walgreens has tried to leverage its nationwide footprint to recruit customers who pick up drugs at its stores into clinical trials , in an effort to diversify participation in studies of new medicines. Other retailers have struggled with similar efforts to expand beyond their core pharmacy operations. Last year, CVS ended its clinical trial endeavors after two years, and earlier this year, Walmart closed several of its medical clinics.
Pharmacy Times
JUNE 14, 2024
Repotrectinib has also shown significant efficacy in ROS1 fusion-positive non¬–small cell lung cancer (NSCLC), which was also studied in the TRIDENT-1 trial.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
JUNE 14, 2024
Virtual primary care company HealthTap is expanding its reach to millions of Americans by now accepting health coverage for it services. | Virtual primary care company HealthTap is expanding its reach to millions of Americans by now accepting health coverage for it services.
Pharmacy Times
JUNE 14, 2024
Zanubrutinib shows potential in treating patients with treatment-naïve high-risk chronic lymphocytic leukemia and/or small lymphocytic lymphoma with del(17p) and/or TP53 mutation.
STAT
JUNE 14, 2024
A blockbuster arthritis drug from Novartis may face a limit on what Colorado health plans pay for the medicine after a state board determined the injectable treatment is “unaffordable” for patients. The Colorado Prescription Drug Affordability Board voted Friday to grant the designation to Cosentyx, which is used to treat conditions such as plaque psoriasis and psoriatic arthritis.
pharmaphorum
JUNE 14, 2024
Stay up-to-date with the latest news in clinical trials with highlights from NMD Pharma, Minoryx Therapeutics, Moonlake Immunotherapeutics, and Ipsen. Discover the groundbreaking developments from 10th to 14th June.
STAT
JUNE 14, 2024
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
pharmaphorum
JUNE 14, 2024
Radiopharma firm Telix abandons Nasdaq listing plans Phil.
Fierce Healthcare
JUNE 14, 2024
A new clinical program launched in Washington last week aims to help facilitate medications for opioid use disorder (MOUD) in emergency rooms across the state. | Funded by opioid settlement funds, ScalaNW is designed to bridge between ER docs with ongoing outpatient care, and to ultimately save the lives of patients with opioid use disorder.
pharmaphorum
JUNE 14, 2024
DeepWell gamifies breathing therapy for mental health Phil.
Pharmacy Times
JUNE 14, 2024
Precision medicine takes a proactive stance by leveraging genetic insights to guide treatment decisions from the outset.
Pharmaceutical Technology
JUNE 14, 2024
If exercised, the option would allow Takeda to license the TKI olverembatinib outside China, Hong Kong, Macau, Taiwan and Russia.
Pharmacy Times
JUNE 14, 2024
Trametinib may become an alternative treatment to hematopoietic stem cell transplantation in patients with relapsed or refractory juvenile myelomonocytic leukemia (JMML).
The Checkup by Singlecare
JUNE 14, 2024
Your liver plays an essential role in maintaining your health by acting as a filter to remove toxins and waste from your blood. When it’s not working properly, it can have serious negative consequences, such as jaundice, mental confusion, edema, or electrolyte imbalances. Because it’s such an important organ, there are lots of supplements that claim to support liver function.
Pharmaceutical Technology
JUNE 14, 2024
AbbVie has made a licence agreement with FutureGen Biopharmaceutical for developing FG-M701 for inflammatory bowel disease (IBD).
Fierce Healthcare
JUNE 14, 2024
COVID-19 patients admitted to hospitals with fewer nursing resources prior to and during the early pandemic were significantly less likely to survive their illness, a recent study found. | The risk of a COVID-19 patient's in-hospital mortality rose by 20% for each additional patient added to a nurse's workload in the months before the pandemic, a recently published analysis found.
Pharmaceutical Technology
JUNE 14, 2024
England’s NHS has reported an 18% increase in the number of people with non-diabetic hyperglycaemia, also known as pre-diabetes.
Expert insights. Personalized for you.
528 
Let's personalize your content